Back
Marvell Technology 10K Form
Sell
35
MRVL
Marvell Technology
Last Price:
$66.76
Seasonality Move:
11.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-16 | 10K | MRVL/Marvell Technology Annual |
2020-12-04 | 10Q | MRVL/Marvell Technology Quarterly |
2020-08-28 | 10Q | MRVL/Marvell Technology Quarterly |
2020-05-29 | 10Q | MRVL/Marvell Technology Quarterly |
2020-03-23 | 10K | MRVL/Marvell Technology Annual |
2019-12-04 | 10Q | MRVL/Marvell Technology Quarterly |
Receive MRVL News And Ratings
See the #1 stock for the next 7 days that we like better than MRVL
MRVL Financial Statistics
Sales & Book Value
Annual Sales: | $5.8B |
---|---|
Cash Flow: | $443.3M |
Price / Cash Flow: | 44.64 |
Annual Sales: | $15.52 |
Price / Book: | 4.62 |
Profitability
EPS (TTM): | -1.02000 |
---|---|
Net Income (TTM): | $-885M |
Gross Margin: | $2.4B |
Return on Equity: | -6.29% |
Return on Assets: | -4.34% |
Marvell Technology Earnings Forecast
Key Marvell Technology Financial Ratios
-
The Gross Profit Margin over the past 28 years for MRVL is 41.31%.
-
The Selling, General & Administrative Expenses for MRVL have been equal to 13.84% of Gross Profit Margin.
-
The Research & Development expenses have been 33.82% of Revenue.
-
The Net Earning history of MRVL is -15.35% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 16 years.
Marvell Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | MRVL |
CUSIP: | G5876H |
Website: | marvell.com |
Debt
Debt-to-Equity Ratio: | 0.3 |
---|---|
Current Ratio: | 1.54 |
Quick Ratio: | 0.98 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 19.44 |
MRVL Technical Analysis vs Fundamental Analysis
Sell
35
Marvell Technology (MRVL)
is a Sell
Is Marvell Technology a Buy or a Sell?
-
Marvell Technology stock is rated a SellThe current Marvell Technology [MRVL] share price is $71.67. The Score for MRVL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.